Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01232-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Jaap L J Hanssen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Center for Infectious Diseases (LU-CID), Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Anti-Bacterial Agents, Trimethoprim, Sulfamethoxazole Drug Combination, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Dutch health insurance company: Zorg en Zekerheid.
Abstract (Originalsprache)
Fluoroquinolones (FQs) are considered the most effective antimicrobial treatment for Gram-negative prosthetic joint infection (GN-PJI). Alternatives are needed due to increasing FQ resistance and side effects. We aimed to compare different targeted antimicrobial strategies for GN-PJI managed by debridement, antibiotics, and implant retention (DAIR) or one-stage revision surgery (1SR) and to review the literature of oral treatment options for GN-PJI. In this prospective, multicenter, registry-based study, all consecutive patients with a PJI caused by a Gram-negative microorganism (including mixed infections with Gram-positive microorganisms), managed with DAIR or 1SR from 2015 to 2020, were included. Minimum follow-up was 1 year. Patients underwent targeted therapy with oral FQ, oral cotrimoxazole, or intravenous or oral β-lactams. Survival analysis was performed with use of Kaplan-Meier and Cox proportional hazards models to identify factors potentially associated with treatment failure. Seventy-four patients who received either FQ ( n = 47, 64%), cotrimoxazole ( n = 13, 18%), or β-lactams ( n = 14, 18%) were included. Surgical strategy consisted of DAIR ( n = 72) or 1SR ( n = 2). Median follow-up was 449 days (interquartile range 89–738 days). Failure free survival did not differ between the FQ (72%) and cotrimoxazole (92%) groups (log rank, P = 0.13). This outcome did not change when excluding all pseudomonal PJI in the FQ group. Cotrimoxazole is a potential effective targeted antimicrobial therapy for patients with GN-PJI. A randomized controlled trial is needed to confirm the findings of this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leiden University Center for Infectious Diseases (LU-CID), Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Orthopedics, Leiden University Medical Centre, Leiden, the Netherlands.
- Department of Orthopedic Surgery, Alrijne Hospital, Leiderdorp, the Netherlands.
- Department of Orthopedic Surgery, Haaglanden Medical Centre, The Hague, the Netherlands.
- Department of Internal Medicine, Alrijne Hospital, Leiderdorp, the Netherlands.
- Department of Traumatology, Hospital Vithas Xanit Estepona, Estepona, Spain.
ORCID-Profile: Jaap L J Hanssen
Förderung
- Dutch health insurance company: Zorg en Zekerheid
Zitieren
APA
Hanssen, J. L. J., van der Wal, R. J. P., Mahdad, R., Keizer, S., Delfos, N. M., van der Lugt, J. C. T., Veldkamp, K. E., Nolte, P. A., Leendertse, M., Gelinck, L. B. S., Mollema, F. P. N., Schippers, E. F., Wattel-Louis, H. G., Nelissen, R. G. H. H., Scheper, H., & de Boer, M. G. J. (2024). Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01232-24
Vancouver
Hanssen JLJ, van der Wal RJP, Mahdad R, Keizer S, Delfos NM, van der Lugt JCT, et al. Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01232-24
BibTeX
@article{Hanssen2024,
author = {Hanssen, Jaap L J and van der Wal, Robert J P and Mahdad, Rachid and Keizer, Stefan and Delfos, Nathalie M and van der Lugt, Joris C T and Veldkamp, Karin Ellen and Nolte, Peter A and Leendertse, Masja and Gelinck, Luc B S and Mollema, Femke P N and Schippers, Emile F and Wattel-Louis, Hanke G and Nelissen, Rob G H H and Scheper, Henk and de Boer, Mark G J},
title = {Targeted antimicrobial regimens for Gram-negative prosthetic joint infections: a prospective multicenter study},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01232-24}
}
EUVIMED